Xeloda (State of Florida DOH Central Pharmacy)
Welcome to the PulseAid listing for the Xeloda drug offered from State of Florida DOH Central Pharmacy. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | State of Florida DOH Central Pharmacy |
NON-PROPRIETARY NAME: | capecitabine |
SUBSTANCE NAME: | CAPECITABINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-07-01 |
END MARKETING DATE: | 0000-00-00 |
Xeloda HUMAN PRESCRIPTION DRUG Details:
Item Description | Xeloda from State of Florida DOH Central Pharmacy |
LABELER NAME: | State of Florida DOH Central Pharmacy |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/1) |
START MARKETING DATE: | 2009-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 53808-0411_15601703-7442-48f3-89f4-44fef66b7514 |
PRODUCT NDC: | 53808-0411 |
APPLICATION NUMBER: | NDA020896 |
Other CAPECITABINE Pharmaceutical Manufacturers / Labelers: